Home > Healthcare > Analytical Instruments > Immunoassay > Lateral Flow Assays Market

Lateral Flow Assays Market Share

  • Report ID: GMI5147
  • Published Date: Jan 2023
  • Report Format: PDF

Lateral Flow Assays Market Share

Some of the key industry participants in the global lateral flow assays market include

  • Bioeasy Biotechnology Inc.
  • Abingdon Health
  • Quidel Corporation
  • Abbott
  • Bio-Rad Laboratories
  • Hologic Inc.
  • Thermo Fischer Scientific
  • F. Hoffmann La Roche
  • OPERON, S.A.
  • bioMerieux SA.

Companies are trying to launch new products and cater to the immediate need of the healthcare sector. For instance, in January 2022, Roche Diagnostics India launched its new lateral flow immunoassay diagnostic solution – the COVID-19 At-Home Test - to improve the detection of the nucleocapsid protein antigen from SARS-CoV-2.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for Lateral flow assays was valued at more than USD 8.7 billion in 2022 and it is anticipated to record a CAGR of over 4.5% between 2023 and 2032.

Cardiac marker testing segment accounted for nearly 26.4% share in 2022 owing to the increase cases of cardiovascular disease as well as the expanding elderly population.

Europe lateral flow assays market is expected to be worth USD 4.6 billion by end of 2032 due to the wide-scale use of point-of-care testing, particularly in the western Europe.

Bioeasy Biotechnology Inc., Quidel Corporation, Abbott, Bio-Rad Laboratories, Hologic Inc., Thermo Fischer Scientific, OPERON, S.A., and bioMerieux SA are some of the leading manufacturers of lateral flow assays.

Lateral Flow Assays Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 482
  • Countries covered: 23
  • Pages: 240
 Download Free Sample